Publication: A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles
A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles
Date
Date
Date
Citations
Gómez, J. M. M., Fischer, S., Csaba, N., Kündig, T. M., Merkle, H. P., Gander, B., & Johansen, P. (2007). A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharmaceutical Research, 24(10), 1927–1935. https://doi.org/10.1007/s11095-007-9318-0
Abstract
Abstract
Abstract
Purpose: Allergen-specific immunotherapy (SIT) requires dozens of subcutaneous injections over 3 to 5years in order to control IgE-mediated hypersensitivity, which is a T-helper 2 (Th2)-associated pathology. This study investigates the use of poly(lactide-co-glycolide) (PLGA) microparticles combined with immunostimulatory oligodeoxynucleotide (CpG), as well as protamine in SIT. Materials and Methods: We prepared microparticle formulations with the major allergen of bee venom, phospholipase A2 (PLA2), and analyzed the effect of co-enca
Metrics
Downloads
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Publisher DOI
Metrics
Downloads
Views
Citations
Gómez, J. M. M., Fischer, S., Csaba, N., Kündig, T. M., Merkle, H. P., Gander, B., & Johansen, P. (2007). A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles. Pharmaceutical Research, 24(10), 1927–1935. https://doi.org/10.1007/s11095-007-9318-0